In patients with cystic fibrosis (CF), despite the availability of many different pharmacologic agents, lung function deteriorates and lung disease progresses and leads to hypercapnic respiratory failure in some patients. In such cases, noninvasive ventilation (NIV) seems to be a promising technique that can be used on demand. This review summarizes the current applications of NIV in clinical settings as well as findings of the clinical trials that involved the delivery of NIV on variable occasions, such as an adjunct to physiotherapy, in nocturnal hypoventilation, and acute and chronic respiratory failure. NIV has been used in patients with CF and with advanced lung disease who are not considered candidates for lung transplantation. It can stabilize lung function, although its effect on hypercapnia is not always evident. Nocturnal NIV has been used in patients with CF and with hypoventilation during sleep but without clear benefits on daytime . NIV as an adjunct to chest physiotherapy may be helpful when desaturation is observed during physiotherapy and when there are signs of respiratory muscle fatigue. NIV use in CF has been increasing, mainly in adult CF centers, and offers patients an opportunity to reach lung transplantation or to overcome acute hypercapnic respiratory failure.
SlyPD, GangellCL, ChenL, WareRS, RanganathanS, MottLS, et al. Risk factors for bronchiectasis in children with cystic fibrosis. N Engl J Med, 2013; 368(21):1963-1970.
3.
RosenowT, OudraadMCJ, MurrayCP, TurkovicL, KuoW, de BruijneM, et al. PRAGMA-CF. A quantitative structural lung disease computed tomography outcome in young children with cystic fibrosis. Am J Respir Crit Care Med, 2015; 191(10):1158-1165.
4.
SandersDB, LiZ, LaxovaA, RockMJ, LevyH, CollinsJ, et al. Risk factors for the progression of cystic fibrosis lung disease throughout childhood. Ann Am Thorac Soc, 2014; 11(1):63-72.
5.
KeremE, VivianiL, ZolinA, MacNeillS, HatziagorouE, EllemunterH, et al. ECFS Patient Registry Steering Group. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry. Eur Respir J, 2014; 43(1):125-133.
HartN, PolkeyMI, ClémentA, BouléM, MoxhamJ, LofasoF, FaurouxB. Changes in pulmonary mechanics with increasing disease severity in children and young adults with cystic fibrosis. Am J Respir Crit Care Med, 2002; 166(1):61-66.
PiperAJ, ParkerS, TorzilloPJ, SullivanCE, ByePT. Nocturnal nasal IPPV stabilizes patients with cystic fibrosis and hypercapnic respiratory failure. Chest, 1992; 102(3):846-850.
10.
HillAT, EdenboroughFP, CaytonRM, StableforthDE. Long-term nasal intermittent positive pressure ventilation in patients with cystic fibrosis and hypercapnic respiratory failure (1991-1996). Respir Med, 1998; 92(3):523-526.
11.
MaddenBP, KariyawasamH, SiddiqiAJ, MachinA, PryorJA, HodsonME. Noninvasive ventilation in cystic fibrosis patients with acute or chronic respiratory failure. Eur Respir J, 2002; 19(2):310-313.
12.
FlightWG, ShawJ, JohnsonS, WebbAK, JonesAM, BentleyAM, Bright-ThomasRJ. Long-term non-invasive ventilation in cystic fibrosis – experience over two decades. J Cyst Fibros, 2012; 11(3):187-192.
13.
FaurouxB, Le RouxE, RavillyS, BellisG, ClémentA. Long-term noninvasive ventilation in patients with cystic fibrosis. Respiration, 2008; 76(2):168-174.
14.
ArchangelidiO, CarrSB, SimmondsNJ, BiltonD, BanyaW, CullinanP. CF-EpiNet. Non-invasive ventilation and clinical outcomes in cystic fibrosis: findings from the UK CF registry. J Cyst Fibros, 2019; 18(5):665-670.
15.
SpoletiniG, PollardK, WatsonR, DarbyMJ, JohnstoneA, EtheringtonC, et al. Noninvasive ventilation in cystic fibrosis: clinical indications and outcomes in a large UK adult cystic fibrosis center. Respir Care, 2021; 66(3):466-474.
16.
FaurouxB, BurgelPR, BoellePY, CracowskiC, Murris-EspinM, Nove-JosserandR, et al. Chronic Respiratory Insufficiency Group of the French National Cystic Fibrosis Federation. Practice of noninvasive ventilation for cystic fibrosis: a nationwide survey in France. Respir Care, 2008; 53(11):1482-1489.
17.
CollinsN, GuptaA, WrightS, GauldL, UrquhartD, BushA. Survey of the use of non-invasive positive pressure ventilation in U.K. and Australasian children with cystic fibrosis. Thorax, 2011; 66(6):538-539.
18.
KeremE, ReismanJ, CoreyM, CannyGJ, LevisonH. Prediction of mortality in patients with cystic fibrosis. N Engl J Med, 1992; 326(18):1187-1191.
19.
GrantonJT, KestenS. The acute effects of nasal positive pressure ventilation in patients with advanced cystic fibrosis. Chest, 1998; 113(4):1013-1018.
20.
SklarMC, DresM, RittayamaiN, WestB, GriecoDL, TeliasI, et al. High-flow nasal oxygen versus noninvasive ventilation in adult patients with cystic fibrosis: a randomized crossover physiological study. Ann Intensive Care, 2018; 8(1):85.
21.
LimaCA, de AndradeAFD, CamposSL, BrandãoDC, FregoneziG, MouratoIP, et al. Effects of noninvasive ventilation on treadmill 6-min walk distance and regional chest wall volumes in cystic fibrosis: randomized controlled trial. Respir Med, 2014; 108(10):1460-1468.
22.
FaurouxB, BouléM, LofasoF, ZérahF, ClémentA, HarfA, IsabeyD. Chest physiotherapy in cystic fibrosis: improved tolerance with nasal pressure support ventilation. Pediatrics, 1999; 103(3):E32.
23.
HollandAE, DenehyL, NtoumenopoulosG, NaughtonMT, WilsonJW. Non-invasive ventilation assists chest physiotherapy in adults with acute exacerbations of cystic fibrosis. Thorax, 2003; 58(10):880-884.
24.
PlacidiG, CornacchiaM, PoleseG, ZanollaL, AssaelBM, BraggionC. Chest physiotherapy with positive airway pressure: a pilot study of short-term effects on sputum clearance in patients with cystic fibrosis and severe airway obstruction. Respir Care, 2006; 51(10):1145-1153.
25.
StanfordG, ParrottH, BiltonD, AgentP, BanyaW, SimmondsN. Randomised cross-over trial evaluating the short-term effects of non-invasive ventilation as an adjunct to airway clearance techniques in adults with cystic fibrosis. BMJ Open Respir Res, 2019; 6(1):e000399.
26.
DwyerTJ, RobbinsL, KellyP, PiperAJ, BellSC, ByePT. Non-invasive ventilation used as an adjunct to airway clearance treatments improves lung function during an acute exacerbation of cystic fibrosis: a randomised trial. J Physiother, 2015; 61(3):142-147.
27.
StanfordG, ParrottH, BiltonD, AgentP. Positive pressure–analysing the effect of the addition of non-invasive ventilation (NIV) to home airway clearance techniques (ACT) in adult cystic fibrosis (CF) patients. Physiother Theory Pract, 2015; 31(4):270-274.
28.
Rodriguez HortalMC, Nygren-BonnierM, HjelteL. Non-invasive ventilation as airway clearance technique in cystic fibrosis. Physiother Res Int, 2017; 22(3):e1667.
29.
ReiterJ, Gileles-HillelA, Cohen-CymberknohM, RosenD, KeremE, GozalD, FornoE. Sleep disorders in cystic fibrosis: a systematic review and meta-analysis. Sleep Med Rev, 2020; 51:101279.
30.
GozalD. Nocturnal ventilatory support in patients with cystic fibrosis: comparison with supplemental oxygen. Eur Respir J, 1997; 10(9):1999-2003.
31.
MilrossMA, PiperAJ, NormanM, BeckerHF, WillsonGN, GrunsteinRR, et al. Low-flow oxygen and bilevel ventilatory support: effects on ventilation during sleep in cystic fibrosis. Am J Respir Crit Care Med, 2001; 163(1):129-134.
32.
YoungAC, WilsonJW, KotsimbosTC, NaughtonMT. Randomised placebo controlled trial of non-invasive ventilation for hypercapnia in cystic fibrosis. Thorax, 2008; 63(1):72-77.
33.
MilrossMA, PiperAJ, DwyerTJ, WongK, BellSC, ByePTP. Non‐Invasive Ventilation in Cystic Fibrosis (NIVCF) Study Group. Non-invasive ventilation versus oxygen therapy in cystic fibrosis: a 12-month randomized trial. Respirology, 2019; 24(12):1191-1197.
